Temozolomide with or without radiotherapy in melanoma with unresectable brain metastases

Journal of Neuro-Oncology

Volumn 76, Issue 1, 2006, Pages 59-64

  Hofmann, Maja ^a   Kiecker, Felix ^a   Wurm, Reinhard ^a   Schlenger, Lorenz ^a   Budach, Volker ^a   Sterry, Wolfram ^a   Trefzer, Uwe ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Brain metastases; Melanoma; Radiotherapy; Stereotactic; Temozolomide; Toxicity; Whole brain radiotherapy

Indexed keywords

TEMOZOLOMIDE;

ABDOMINAL CRAMP; ADULT; ANEMIA; ANOREXIA; ANTINEOPLASTIC ACTIVITY; APATHY; ARTICLE; BRAIN METASTASIS; BRAIN RADIOGRAPHY; CANCER CONTROL; CANCER GROWTH; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONSTIPATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG PENETRATION; DRUG SAFETY; DUODENUM PERFORATION; EMOTIONAL DISORDER; FEMALE; GRANULOCYTOPENIA; HEADACHE; HUMAN; INFECTION; LEUKOPENIA; MALE; MAXIMUM PERMISSIBLE DOSE; MELANOMA; METASTASIS POTENTIAL; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRURITUS; RETROSPECTIVE STUDY; SURVIVAL TIME; THROMBOCYTOPENIA;

ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; DACARBAZINE; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; SKIN NEOPLASMS; STEREOTAXIC TECHNIQUES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 30944464394     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-005-2914-0     Document Type: Article

References (36)

1. DE Bullard EB Cox HF Seigler 1981 Central nervous system metastases in malignant melanoma Neurosurgery 8 26-30 7207769 1:STN:280:Bi6C2cbhs1c%3D
2. V Franciosi G Cocconi M Michiara F Di Costanzo V Fosser M Tonato P Carlini C Boni S Di Sarra 1999 Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma: A prospective study Cancer 85 1599-1605 10193952 10.1002/ (SICI)1097-0142(19990401)85:7<1599::AID-CNCR23>3.0.CO;2-# 1:CAS:528:DyaK1MXitlaqs7g%3D
3. JM Richards D Gale N Mehta T Lestingi 1999 Combination of chemotherapy with interleukin-2 and interferon alfa for the treatment of metastatic melanoma J Clin Oncol 17 651-657 10080611 1:CAS:528:DyaK1MXht1Wmu7c%3D
4. ES Newlands MF Stevens SR Wedge RT Wheelhouse C Brock 1997 Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials Cancer Treat Rev 23 35-61 9189180 10.1016/ S0305-7372(97)90019-0 1:CAS:528:DyaK2sXktFOrt7w%3D
5. WK Yung MD Prados R Yaya-Tur SS Rosenfeld M Brada HS Friedman R Albright J Olson SM Chang AM O'Neill AH Friedman J Bruner N Yue M Dugan S Zaknoen VA Levin 1999 Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group J Clin Oncol 17 2762-2771 10561351 1:CAS:528:DyaK1MXmtlWru7s%3D
6. WK Yung RE Albright J Olson R Fredericks K Fink MD Prados M Brada A Spence RJ Hohl W Shapiro M Glantz H Greenberg RG Selker NA Vick R Rampling H Friedman P Phillips J Bruner N Yue D Osoba S Zaknoen VA Levin 2000 A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse Br J Cancer 83 588-593 10944597 10.1054/bjoc.2000.1316 1:CAS:528:DC%2BD3cXmvVCgsrs%3D
7. LE Abrey JD Olson JJ Raizer M Mack A Rodavitch DY Boutros MG Malkin 2001 A phase II trial of temozolomide for patients with recurrent or progressive brain metastases J Neurooncol 53 259-265 11718258 10.1023/ A:1012226718323 1:STN:280:DC%2BD3Mnnt1Crsw%3D%3D
8. MR Middleton JJ Grob N Aaronson G Fierlbeck W Tilgen S Seiter M Gore S Aamdal J Cebon A Coates B Dreno M Henz D Schadendorf A Kapp J Weiss U Fraass P Statkevich M Muller N Thatcher 2000 Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma J Clin Oncol 18 158-166 10623706 1:CAS:528:DC%2BD3cXmtFSqsQ%3D%3D
9. NM Bleehen ES Newlands SM Lee N Thatcher P Selby AH Calvert GJ Rustin M Brampton MF Stevens 1995 Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma J Clin Oncol 13 910-913 7707118 1:STN:280:ByqB383jtFw%3D
10. SS Agarwala JM Kirkwood M Gore B Dreno N Thatcher B Czarnetski M Atkins A Buzaid D Skarlos EM Rankin 2004 Temozolomide for the treatment of brain metastases associated with metastatic melanoma: A phase II study J Clin Oncol 22 2101-2107 15169796 10.1200/JCO.2004.11.044 1:CAS:528:DC%2BD2cXpsVWlsLg%3D
11. MJ Paul Y Summers AH Calvert G Rustin MH Brampton N Thatcher MR Middleton 2002 Effect of temozolomide on central nervous system relapse in patients with advanced melanoma Melanoma Res 12 175-178 11930115 10.1097/00008390-200204000-00011 1:CAS:528:DC%2BD38XjslCqsrw%3D
12. K Brega WA Robinson K Winston W Wittenberg 1990 Surgical treatment of brain metastases in malignant melanoma Cancer 66 2105-2110 2224765 1:STN:280:By6D38bgs1c%3D
13. M Wronski E Arbit 2000 Surgical treatment of brain metastases from melanoma: A retrospective study of 91 patients J Neurosurg 93 9-18 10883899 1:STN:280:DC%2BD3czjvV2mug%3D%3D
14. JC Buchsbaum JH Suh SY Lee MA Chidel JF Greskovich GH Barnett 2002 Survival by radiation therapy oncology group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma: A retrospective study Cancer 94 2265-2272 12001126 10.1002/cncr.10426
15. J Overgaard 1986 The role of radiotherapy in recurrent and metastatic malignant melanoma: A clinical radiobiological study Int J Radiat Oncol Biol Phys 12 867-872 2424880 1:STN:280:BimB2M%2FitlM%3D
16. SK Seung PK Sneed MW McDermott HK Shu SP Leong S Chang PL Petti V Smith LJ Verhey WM Wara TL Phillips DA Larson 1998 Gamma knife radiosurgery for malignant melanoma brain metastases Cancer J Sci Am 4 103-109 9532412 1:STN:280:DyaK1c7ptlGrsg%3D%3D
17. V Mingione M Oliveira D Prasad M Steiner L Steiner 2002 Gamma surgery for melanoma metastases in the brain J Neurosurg 96 544-551 11883840
18. E Shaw C Scott L Souhami R Dinapoli R Kline J Loeffler N Farnan 2000 Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: Final report of RTOG protocol 90-05 Int J Radiat Oncol Biol Phys 47 291-298 10802351 10.1016/ S0360-3016(99)00507-6 1:STN:280:DC%2BD3c3mtlyjuw%3D%3D
19. JG Douglas K Margolin 2002 The treatment of brain metastases from malignant melanoma Semin Oncol 29 518-524 12407517 10.1053/ sonc.2002.35247
20. MB Atkins MT Lotze JP Dutcher RI Fisher G Weiss K Margolin J Abrams M Sznol D Parkinson M Hawkins C Paradise L Kunkel SA Rosenberg 1999 High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: Analysis of 270 patients treated between 1985 and 1993 J Clin Oncol 17 2105-2116 10561265 1:CAS:528:DyaK1MXkvVSmur4%3D
21. C Conill M Gonzalez-Cao S Jorcano S Puig J Malvehy R Marti T Castel 2004 Temozolomide as prophylaxis for melanoma brain metastases Melanoma Res 14 73-74 15091198 1:CAS:528:DC%2BD2cXjs1agt78%3D
22. JH Sampson JH Carter Jr. AH Friedman HF Seigler 1998 Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma J Neurosurg 88 11-20 9420067 1:STN:280:DyaK1c%2FotVagtg%3D%3D
23. D Bafaloukos D Tsoutsos G Fountzilas H Linardou C Christodoulou HP Kalofonos E Briassoulis P Panagiotou H Hatzichristou H Gogas 2004 The effect of temozolomide-based chemotherapy in patients with cerebral metastases from melanoma Melanoma Res 14 289-294 15305160 1:CAS:528:DC%2BD2cXmsVCgtLg%3D
24. K Margolin B Atkins A Thompson S Ernstoff J Weber L Flaherty I Clark G Weiss J Sosman P Dutcher J Gollob J Longmate D Johnson 2002 Temozolomide and whole brain irradiation in melanoma metastatic to the brain: A phase II trial of the Cytokine Working Group J Cancer Res Clin Oncol 128 214-218 11935312 10.1007/s00432-002-0323-8 1:CAS:528:DC%2BD38XksFGnurg%3D
25. G Stevens I Firth A Coates 1992 Cerebral metastases from malignant melanoma Radiother Oncol 23 185-191 1574597 10.1016/0167-8140(92)90329-S 1:STN:280:By2B2crgvVw%3D
26. RF Young 1998 Radiosurgery for the treatment of brain metastases Semin Surg Oncol 14 70-78 9407633 1:STN:280:DyaK1c%2FntFGmuw%3D%3D
27. Y Mori D Kondziolka JC Flickinger JM Kirkwood S Agarwala LD Lunsford 1998 Stereotactic radiosurgery for cerebral metastatic melanoma: Factors affecting local disease control and survival Int J Radiat Oncol Biol Phys 42 581-589 9806518 10.1016/S0360-3016(98)00272-7 1:STN:280:DyaK1M%2FitFemtw%3D%3D
28. JJ Grob J Regis R Laurans M Delaunay P Wolkenstein K Paul P Souteyrand MC Koeppel X Murraciole JC Perragut JJ Bonerandi 1998 Radiosurgery without whole brain radiotherapy in melanoma brain metastases. Club de Cancerologie Cutanee Eur J Cancer 34 1187-1192 9849477 10.1016/ S0959-8049(98)00026-4 1:STN:280:DyaK1M%2Fms1eguw%3D%3D
29. C Conill J Fernandez-Ibiza J Malvehy S Puig M Sanchez T Castel 2004 [Temozolomide in patients with melanoma brain metastases treated with whole brain irradiation] Med Clin (Barc) 122 413-415 10.1157/13059545
30. G Biasco MA Pantaleo S Casadei 2001 Treatment of brain metastases of malignant melanoma with temozolomide N Engl J Med 345 621-622 11529230 10.1056/NEJM200108233450817 1:STN:280:DC%2BD3Mvos1yitQ%3D%3D
31. J Dvorak B Melichar J Zizka D Hadzi-Nikolov J Petera 2004 Complete response of multiple melanoma brain metastases after treatment with temozolomide Onkologie 27 171-174 15138351 10.1159/000076908 1:STN:280:DC%2BD2c3ktVegsw%3D%3D
32. C Conill S Puig I Toscas T Castel 2002 Complete response of cerebral metastasic melanoma after a combined treatment of radiotherapy and temozolomide Med Clin (Barc) 119 758-759
33. WJ Hwu SE Krown JH Menell KS Panageas J Merrell LA Lamb LJ Williams CJ Quinn T Foster PB Chapman PO Livingston JD Wolchok AN Houghton 2003 Phase II study of temozolomide plus thalidomide for the treatment of metastatic melanoma J Clin Oncol 21 3351-3356 12947072 10.1200/ JCO.2003.02.061 1:CAS:528:DC%2BD2cXps1akurc%3D
34. H Kurzen S Schmitt H Naher T Mohler 2003 Inhibition of angiogenesis by non-toxic doses of temozolomide Anticancer Drugs 14 515-522 12960735 1:CAS:528:DC%2BD3sXmvF2itr0%3D
35. ES Newlands GR Blackledge JA Slack GJ Rustin DB Smith NS Stuart CP Quarterman R Hoffman MF Stevens 1992 Phase I trial of temozolomide Br J Cancer 65 287-291 1739631 1:STN:280:By2C2MzmvFA%3D
36. YB Su S Sohn SE Krown PO Livingston JD Wolchok C Quinn L Williams T Foster KA Sepkowitz PB Chapman 2004 Selective CD4+ lymphopenia in melanoma patients treated with temozolomide: A toxicity with therapeutic implications J Clin Oncol 22 610-616 14726505 10.1200/JCO.2004.07.060 1:CAS:528:DC%2BD2cXpsVajs7s%3D